After treading the commercial path alone for the past year and change, Revance Therapeutics, maker of the Botox rival Daxxify, has agreed to fly the Crown Laboratories flag.
Revance and Crown—a privately held skin care company with multiple marketed products of its own—are merging, the companies said in a release Monday.
